A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
about
Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal CancerLong non-coding RNAs in colorectal cancerNon-coding landscapes of colorectal cancerMetastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targetsLong Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Co-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data.Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluationLncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method.Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancerLong noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.Identification of a six-lncRNA signature associated with recurrence of ovarian cancer.A three-lncRNA expression signature associated with the prognosis of gastric cancer patients.Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes.Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma.Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas.A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transitionA potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patientsConstruction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancerTRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcomeARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancerA potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.Long non-coding RNA AK027294 involves in the process of proliferation, migration, and apoptosis of colorectal cancer cells.THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer.A long non-coding RNA signature to improve prognosis prediction of gastric cancer.Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinomaBiomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation.A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcomeIdentification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal CancerCo-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
P2860
Q26752457-A0E92D31-7001-4C25-8005-98C73A6208AFQ26774282-2BC995F1-FED0-4E13-B637-640BF1C013C9Q26778014-6EA5181B-E7EC-4375-BC63-A6FE3CCC7C81Q28070411-E6B9ABD7-18DF-4B64-A7A2-DF18D4714E63Q28088454-810E6C74-5A10-427C-B630-BBED306379F0Q30993174-A4885FFD-0511-4A76-9A80-23F5BB512789Q33559988-4DF9BA72-023F-4DFB-AEE6-42E56DAC276DQ33582732-C53EF759-B309-4E54-95F3-C721DC5201F9Q33598237-ABACC679-D421-44AC-B366-663F8299DAA1Q33671544-CA4AD0C8-879B-463D-82F8-E04144FB87ECQ33677576-7AF8DC08-BEDB-4466-BFEB-58279CF02B41Q33775233-BA1127D4-9667-40C7-95AD-38F5EFFA7D3FQ34786561-AECE5286-A615-4E8F-9353-4F055E9C092DQ35142413-CCF1C71E-6845-44E9-9C4F-5E72813EF1D0Q35677979-6B58A10C-E256-4F07-9276-E0BC30AB49ABQ35817368-62E5DA3C-6239-46DF-A29B-498A717328E3Q35840904-1815D084-2526-4951-A44E-A11BD514CCF6Q35857169-E043D7BB-9886-4DF2-9C50-046218EB805DQ36053910-06BBA9BC-73AA-46AE-A927-CBCE9497BE54Q36095186-4D89950F-E2CD-4F40-AE25-ECA1996BDBBCQ36262493-A197E385-EA3D-4048-82E0-7CF900ABF6D2Q36413098-8872D7C7-68CA-470B-9B8F-9E6B525F5E19Q36413189-836A767F-C36E-455F-B4F3-04949DD6C7A1Q36414270-1347C07E-1720-4D1C-97B1-043B5C8A2D46Q36774904-17ED97A4-5AD3-4E5E-BB01-E51670706184Q36908895-D2481341-C0A3-4212-86C1-CD0E6532F6C9Q36996542-C38BC2AB-8EBE-4830-914A-49A3E0BC7D5BQ36998226-91790413-AA90-4EDB-AF99-41024B969AD6Q37022234-CC16DD8D-F387-4565-ACB6-F8C7521F7889Q37190414-29F9E96A-624C-46F5-BF5C-45E212F65B99Q37208205-B7A51A5F-C435-46D9-B6E6-61E053428ABDQ37261166-FBF2F108-266F-4B6C-BE37-D1E64F6DF280Q37268013-7D8EF880-986E-4870-919D-633D919AEEC1Q37301923-6BFFFC71-2199-455F-A6AE-2C9A8EC82922Q37344508-E5F28D5F-329D-4043-A0C4-6D9FD7578B21Q37353877-F592B90A-6A38-4207-AAEA-97F18BEE0719Q37362685-1DF2DE43-256B-4533-BEDD-1687364625FBQ37457709-72954615-464E-478F-A1C3-4F03EB2220B8Q37564218-57F33B1B-F341-4379-B338-FDB7CEFBCDDFQ37628972-C803D17A-97AC-49D7-BEBB-2D58ADA30A7C
P2860
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@ast
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@en
type
label
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@ast
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@en
prefLabel
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@ast
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.
@en
P2093
Chen-Yang Yu
Hao-Yan Chen
Ji-Lin Wang
Jing-Yuan Fang
P2860
P304
P356
10.18632/ONCOTARGET.1895
P407
P577
2014-04-01T00:00:00Z